Patents Examined by Samuel W. Lin
  • Patent number: 6841532
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: January 11, 2005
    Assignee: CV Molecular Therapeutics, Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Patent number: 6677440
    Abstract: A process for the preparation of a pure form of protein, wherein the protein is protease activating blood clotting factor VII, the proenzyme for the protease, or a mixture of both the-protease and the proenzyme, is described. The protein is obtained from biological fluids or through genetic engineering and is isolated by anion- and/or cation-exchange chromatography at a pH below the isoelectric point of the protein to be isolated, or by a combination of anion- or cation-exchange chromatography with a chromatography process and/or fractional precipitation at pH between 2.5 and 9.0.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: January 13, 2004
    Assignee: Aventis Behring GmbH
    Inventors: Juergen Roemisch, Annette Feussner, Hans-Arnold Stoehr